Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case report

Am J Hematol. 1999 Mar;60(3):225-8. doi: 10.1002/(sici)1096-8652(199903)60:3<225::aid-ajh10>3.0.co;2-s.

Abstract

Cyclic acquired amegakaryocytic thrombocytopenic purpura (AATP) is a rare disorder characterized by periodic fluctuations in the platelet counts due to a defect in the platelet production. We describe a 42-year-old female with cyclic AATP, in whom the cyclic fluctuations in the platelet counts ceased with danazol therapy. The pathogenesis of the disease and the possible mechanisms of danazol action have been reviewed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Danazol / administration & dosage*
  • Estrogen Antagonists / administration & dosage*
  • Female
  • Humans
  • Megakaryocytes / pathology
  • Purpura, Thrombocytopenic / drug therapy*
  • Purpura, Thrombocytopenic / pathology
  • Purpura, Thrombocytopenic / physiopathology

Substances

  • Estrogen Antagonists
  • Danazol